SenesTech, Inc. (SNES)
0.829
-0.01
(-0.71%)
USD |
NASDAQ |
Oct 06, 16:00
0.83
0.00 (0.00%)
After-Hours: 20:00
SenesTech Profit Margin (Quarterly) : -237.9% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -237.9% |
| March 31, 2026 | -418.5% |
| December 31, 2025 | -428.5% |
| September 30, 2025 | -188.1% |
| June 30, 2025 | -258.6% |
| March 31, 2025 | -343.3% |
| December 31, 2024 | -250.5% |
| September 30, 2024 | -313.9% |
| June 30, 2024 | -345.1% |
| March 31, 2024 | -441.4% |
| December 31, 2023 | -587.5% |
| September 30, 2023 | -540.8% |
| June 30, 2023 | -653.4% |
| March 31, 2023 | -874.2% |
| December 31, 2022 | -723.2% |
| September 30, 2022 | -1.06K% |
| June 30, 2022 | -927.4% |
| March 31, 2022 | -1.20K% |
| December 31, 2021 | -1.48K% |
| Date | Value |
|---|---|
| September 30, 2021 | -1.23K% |
| June 30, 2021 | -1.06K% |
| March 31, 2021 | -2.07K% |
| December 31, 2020 | -2.14K% |
| September 30, 2020 | -2.49K% |
| June 30, 2020 | -2.29K% |
| March 31, 2020 | -7.38K% |
| December 31, 2019 | -4.34K% |
| September 30, 2019 | -7.18K% |
| June 30, 2019 | -9.54K% |
| March 31, 2019 | -12.44K% |
| December 31, 2018 | -1.92K% |
| September 30, 2018 | -2.70K% |
| June 30, 2018 | -11.42K% |
| March 31, 2018 | -14.03K% |
| December 31, 2017 | -12.84K% |
| September 30, 2017 | -17.28K% |
| June 30, 2017 | -35.83K% |
| March 31, 2017 | -49.36K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Enveric Biosciences, Inc. | -- |
| LENZ Therapeutics, Inc. | -581.8% |
| Impact BioMedical, Inc. | -23.33K% |
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -84.01% |
| Return on Assets | -59.99% |
| Return on Invested Capital | -63.72% |
| Gross Profit Margin (Quarterly) | 69.74% |
| Operating Margin (Quarterly) | -241.8% |
| Return on Net Operating Assets | -164.3% |